✦ LIBER ✦

Immune biomarkers in immunotherapeutic trials for type 1 diabetes: Cui prodest?

✍ Scribed by Culina, S. (author);Mallone, R. (author)

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immune biomarkers in immunotherapeutic t

✍ Culina, S. (author);Mallone, R. (author) 📂 Article 📅 2012 🏛 Masson Editeur 🌐 French ⚖ 503 KB

Biomarkers for immune intervention trial

✍ Mallone, Roberto; Roep, Bart O. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 532 KB

CRITERIA FOR IMMUNE TRIALS IN TYPE I DIA

✍ Pozzilli, P.; Skyler, J.S.; Stiller, C.R.; Kolb, H.; Bach, J.-F.; Eisenbarth, G. 📂 Article 📅 1989 🏛 The Lancet 🌐 English ⚖ 156 KB

Immunotherapeutic agents in type 1 diabe

✍ Gunjan Y. Gandhi; M. Hassan Murad; David N. Flynn; Mohamed B. Elamin; Patricia J 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 317 KB

Innate and adaptive immune gene expressi

✍ D. Han; X. Cai; J. Wen; D. Matheson; J. S. Skyler; N. S. Kenyon; Z. Chen 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 331 KB

Progress in immune-based therapies for t

✍ von Herrath, M.; Peakman, M.; Roep, B. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 493 KB